https://www.israelhealthcarenews.com/article/909397648-new-memoir-recounts-mercury-poisoning-medical-failure-recovery-through-detoxification-indigenous-ancestral-healing Israel Healthcare News en PressRelease 2026-05-01T19:39:34+00:00 New Memoir Recounts Mercury Poisoning, Medical Failure & Recovery Through Detoxification, Indigenous & Ancestral Healing https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24844974-awakening-in-an-age-of-metals-b-1500x1150.jpeg https://www.israelhealthcarenews.com/article/909738773-inspiremd-announces-fda-approval-of-investigational-device-exemption-application-for-cguardians-iii-pivotal-study-of-the-switchguard-neuro-protection Israel Healthcare News en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.israelhealthcarenews.com/article/909738775-inspiremd-initiates-voluntary-u-s-recall-of-cguard-prime-135-cm-carotid-stent-delivery-system Israel Healthcare News en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.israelhealthcarenews.com/article/909648409-nasus-pharma-to-participate-in-upcoming-investor-conferences Israel Healthcare News en PressRelease 2026-05-01T13:13:59+00:00 Nasus Pharma to Participate in Upcoming Investor Conferences https://ml-eu.globenewswire.com/media/635331e1-7b05-412a-b2db-eebfda31ae81/small/nasus-pharma-logo-png.png https://www.israelhealthcarenews.com/article/909469904-intercure-announces-2025-results-with-nis-270-million-in-revenue-and-positive-operating-cash-flow Israel Healthcare News en PressRelease 2026-04-30T22:05:00+00:00 InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow https://ml.globenewswire.com/media/7ccabaed-d117-4a39-a756-85fc081ede2f/small/logo-jpg.jpg https://www.israelhealthcarenews.com/article/909340879-teva-s-2025-healthy-future-report-highlights-environmental-and-access-to-medicines-progress-including-meeting-all-sustainability-linked-bond-targets Israel Healthcare News en PressRelease 2026-04-30T12:30:00+00:00 Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.israelhealthcarenews.com/article/909341014-enlivex-treasury-portfolio-update-listing-of-the-rain-token-on-htx-a-leading-cryptocurrency-exchange Israel Healthcare News en PressRelease 2026-04-30T12:30:00+00:00 Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg